Today, there has been large and unusual put option activity in Johnson & Johnson (JNJ) after the stock's recent rise. The ...

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does ...

Johnson & Johnson (JNJ) stock soared to a record $268.69, up 71% annually, as analysts boost price targets and institutional ...

Johnson & Johnson stock makes good drugs, but it's valuation isn't great.

Johnson & Johnson (NYSE:JNJ) was among Jim Cramer’s stock calls on Mad Money, as he highlighted the AI opportunities in ...

Johnson & Johnson reports earnings on Wednesday. Investors may be paying attention to tariff-related developments more so than the company's actual growth rate. Historically, Johnson & Johnson has ...

Recent chatter on X about Johnson & Johnson (JNJ) has been buzzing with reactions to the company's latest earnings report and raised 2024 guidance. Posts highlight a notable 6% stock price increase ...

Johnson & Johnson's performance over the past five years has been disappointing. Investors didn't lose money, though. Its future could be bright, and it's a solid dividend payer. 10 stocks we like ...

Johnson & Johnson doesn't need GLP-1 drugs to grow, and that's good news for long-term investors.

Johnson & Johnson (NYSE: JNJ) will release earnings for the fourth quarter before the opening bell on Wednesday, Jan. 21. Analysts expect the company to report fourth-quarter earnings of $2.47 per ...